Patent ID: 8232072

Claim:
A method for counseling a subject who has been administered with a nicotine immunogenic composition, on whether it is an advantageous time for the subject in need thereof to quit smoking, comprising (a) measuring the level of anti-nicotine antibodies in serum from the subject; and (b) counseling the subject that it is an advantageous time to quit smoking if the subject's serum anti-nicotine antibody levels are at or above a predetermined first specified threshold level of serum anti-nicotine antibodies and/or that it is not an advantageous time to quit smoking if the subject's measured level of serum anti-nicotine antibody levels are below the predetermined first specified threshold level of serum anti-nicotine antibodies, wherein said first specified threshold level of serum anti-nicotine antibodies is at least about 6 ug/ml.